[Lenalidomide, rituximab and dexamethasone for the treatment of recurrent/refractory or elderly newly diagnosed patients with primary central nervous system lymphoma: 5 cases report and literature review]
Autor: | J F, Bai, R, Feng, H X, Han, T, Wang, J T, Li, C L, Zhang, H, Liu |
---|---|
Rok vydání: | 2020 |
Předmět: | |
Zdroj: | Chinese Journal of Hematology |
ISSN: | 0253-2727 |
Databáze: | OpenAIRE |
Externí odkaz: |